Fixed drug eruption due to meloxicam

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 5, 2011, Pages 419-420

  Kepil Ozdemir, S ^a   Oner Erkekol, F ^a   Aydin, O ^a   Celik, G E ^a   Misirligil, Z ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Crossreaction; Fixed drug eruption; Meloxicam; Oxicam; Patch tests

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; FLURBIPROFEN; IBUPROFEN; MELOXICAM; NAPROXEN; NIMESULIDE; PIROXICAM; PLACEBO;

ADULT; CASE REPORT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DRUG DOSE INCREASE; DRUG RECHALLENGE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FIXED DRUG ERUPTION; HUMAN; NOTE; PATCH TEST; RASH; SINGLE BLIND PROCEDURE; VULVA PRURITUS;

ADRENAL CORTEX HORMONES; ADULT; CROSS REACTIONS; DIAGNOSTIC ERRORS; DRUG DOSAGE CALCULATIONS; DRUG ERUPTIONS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; KNEE; MEDICATION ERRORS; PRURITUS VULVAE; RHEUMATIC DISEASES; SKIN TESTS; THIAZINES; THIAZOLES;

EID: 80051729466     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Ozkaya E. Fixed drug eruption: state of art. J Dtsch Dermatol Ges. 2008;6:181-188.
2. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009;9:316-321.
3. Savin JA. Current causes of fixed drug eruption in the UK. Br J Dermatol. 2001;145:667-668.
4. Ordoqui E, De Barrio M, Rodriguez VM, Herrero T, Gil PJ, Baeza ML. Cross-sensitivity among oxicams in piroxicam caused fixed drug eruption: two case reports. Allergy. 1995; 50:741-744.
5. Montoro J, Díaz M, Genís C, Lozano A, Bertomeu F. Nonpigmenting cutaneous-mucosal fixed drug eruption due to piroxicam. Allergol Immunopathol (Madr). 2003;31:53-55.
6. Cuerda Galindo E, Goday Buján JJ, García Silva JM, Martínez W, Verea Hernando M, Fonseca E. Fixed drug eruption from piroxicam. J Eur Acad Dermatol Venereol. 2004;18:586-587.
7. Fernández-Jorge B, Goday JJ, Almagro M, Fonseca E. Fixed drug eruption due to piroxicam. Actas Dermosifiliogr. 2008;99:239-240.
8. Celik G, Erkekol FO, Bavbek S, Dursun B, Misirligil Z. Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance. Ann Allergy Asthma Immunol. 2005;95:33-37.
9. Goksel O, Aydin O, Misirligil Z, Demirel YS, Bavbek S. Safety of meloxicam in patients with aspirin/non-steroidal antiinfl ammatory drug-induced urticaria and angioedema. J Dermatol. 2010;37:973-979.
10. Ozkaya E. Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole. Eur J Dermatol. 2006;16:591-592.